conventional diagnostics.

Our product is an AI platform that transforms everyday speech into a health signal. Through simple, non-invasive monthly voice check-ins and short text interactions, Hea analyzes emotional, cognitive, and speech biomarkers. These subtle changes reflect early systemic health risks that standard tests often miss. Clinical research shows that voice carries predictive markers of conditions like cardiovascular disease, diabetes, neurological disorders, and mental health decline. Hea brings this science into practice.

For consumers (B2C), Hea is a personal health guardian — affordable, always-on, and accessible anywhere. It empowers individuals to take control of their health, offering peace of mind and actionable insights long before symptoms appear. For insurers, clinics, and health systems (B2B2C), Hea reduces healthcare costs by preventing hospitalizations, enabling earlier interventions, and improving population health outcomes.

Our key innovation is voice-based health intelligence — a new data layer for medicine. It is continuous, scalable, and cost-effective, unlocking proactive healthcare at population scale. Our proprietary metric, First-Time Detected Disease (FDD), measures the real impact in lives saved and costs avoided, making outcomes tangible for both individuals and partners.

Hea was founded by a team of serial entrepreneurs and HealthTech experts with proven exits, deep AI expertise, and global scaling experience. Our mission is bold yet clear: to make proactive healthcare the global standard so that preventable deaths truly become preventable.